March 14 Product: Madrigals Rezdiffra Indication: MASH In one of the years most highly anticipated FDA decisions, Madrigal Pharmaceuticals won approval Thursday for resmetiromhenceforth to be known as Rezdiffraas the first-ever treatment for metabolic dysfunction-associated steatohepatitis (MASH), formerly noncirrhotic non-alcoholic steatohepatitis (NASH)
Lasting freshness provided
137 Non-benzodiazepines Non-benzodiazepines, also called benzodiazepine-like drugs, such as zaleplon (Sonata), zolpidem, zopiclone (Imovane), and eszopiclone, act on fewer brain receptors than benzodiazepines and therefore have different side effects than benzodiazepines
Melanin is responsible for skin pigmentation, and by increasing its levels, Melanotan 2 may promote a deeper, tanned complexion without the need for prolonged sun exposure